- Home
- WORX vs PRFX Comparison
WORX vs PRFX Comparison
Compare WORX & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- PRFX
- Stock Information
- Founded
- WORX N/A
- PRFX 2007
- Country
- WORX United States
- PRFX Israel
- Employees
- WORX N/A
- PRFX N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- WORX Consumer Discretionary
- PRFX Health Care
- Exchange
- WORX Nasdaq
- PRFX Nasdaq
- Market Cap
- WORX 2.5M
- PRFX 2.8M
- IPO Year
- WORX N/A
- PRFX 2020
- Fundamental
- Price
- WORX $0.30
- PRFX $1.37
- Analyst Decision
- WORX
- PRFX Hold
- Analyst Count
- WORX 0
- PRFX 1
- Target Price
- WORX N/A
- PRFX N/A
- AVG Volume (30 Days)
- WORX 3.5M
- PRFX 155.6K
- Earning Date
- WORX 11-13-2025
- PRFX 11-14-2025
- Dividend Yield
- WORX N/A
- PRFX N/A
- EPS Growth
- WORX N/A
- PRFX N/A
- EPS
- WORX N/A
- PRFX N/A
- Revenue
- WORX $2,838,404.00
- PRFX N/A
- Revenue This Year
- WORX N/A
- PRFX N/A
- Revenue Next Year
- WORX N/A
- PRFX N/A
- P/E Ratio
- WORX N/A
- PRFX N/A
- Revenue Growth
- WORX N/A
- PRFX N/A
- 52 Week Low
- WORX $0.26
- PRFX $1.25
- 52 Week High
- WORX $3.31
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- WORX 46.28
- PRFX 45.55
- Support Level
- WORX $0.28
- PRFX $1.34
- Resistance Level
- WORX $0.40
- PRFX $1.50
- Average True Range (ATR)
- WORX 0.03
- PRFX 0.08
- MACD
- WORX 0.00
- PRFX -0.00
- Stochastic Oscillator
- WORX 12.50
- PRFX 18.26
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.